Published in Neuropathol Appl Neurobiol on July 22, 1980
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest (2006) 2.75
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J Clin Invest (2006) 2.32
Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry (1988) 1.69
Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J Exp Med (1986) 1.56
The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol (2001) 1.56
Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studies. Clin Exp Immunol (1982) 0.88
Brain tissue immunoglobulins in adrenoleukodystrophy: a comparison with multiple sclerosis and systemic lupus erythematosus. Acta Neuropathol (1983) 0.86
Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ? Acta Neuropathol Commun (2015) 0.84
Immunoglobulin M in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry (1989) 0.82
Antibody to myelin basic protein in extracts of multiple sclerosis brain. Immunology (1981) 0.82
Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain. Clin Exp Immunol (1983) 0.81
Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens? Clin Exp Immunol (1983) 0.81
Monoclonal antibodies as disease modifying therapy in multiple sclerosis. Curr Neurol Neurosci Rep (2013) 0.79
Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int (2011) 0.78
The Ins and Outs of B Cells in Multiple Sclerosis. Front Immunol (2015) 0.78
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis. Expert Opin Biol Ther (2016) 0.78
T lymphocyte-derived demyelinating activity in multiple sclerosis patients in relapse. J Neurol Neurosurg Psychiatry (1987) 0.77
Aetiological role of viruses in multiple sclerosis: a review. J R Soc Med (1986) 0.75
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A (1985) 4.97
Plaques, tangles and dementia. A quantitative study. J Neurol Sci (1982) 4.52
Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88
Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37
Axonal damage: a key predictor of outcome in human CNS diseases. Brain (2003) 2.27
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci (1982) 2.17
Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology (2011) 2.15
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology (2006) 2.10
Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J Neurol Sci (1982) 2.02
The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci (1989) 1.95
Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94
Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (1997) 1.84
Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia (1995) 1.76
Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci (1972) 1.76
The cortex of the primary auditory area in Alzheimer's disease. Brain Res (1986) 1.71
The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1984) 1.71
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry (2001) 1.70
Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain (2004) 1.63
Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol Appl Neurobiol (2000) 1.63
Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain (2000) 1.62
Monoclonal antibody to macrophages (EMB/11) labels macrophages and microglial cells in human brain. J Clin Pathol (1986) 1.60
Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol (2000) 1.60
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain (2001) 1.60
White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke (2001) 1.59
Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (1997) 1.58
Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.56
Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci (1983) 1.53
The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.52
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience (1995) 1.48
Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study. Am J Psychiatry (2000) 1.48
The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain (1999) 1.47
The contribution of demyelination to axonal loss in multiple sclerosis. Brain (2006) 1.46
The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol (2004) 1.46
Human and viral gene detection in routine paraffin embedded tissue by in situ hybridisation with biotinylated probes: viral localisation in herpes encephalitis. J Clin Pathol (1986) 1.45
Multiple sclerosis with clinical and radiological features of cerebral tumour. J Neurol Neurosurg Psychiatry (1982) 1.45
Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain (1987) 1.44
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41
Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma. Clin Endocrinol (Oxf) (1989) 1.41
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol (1997) 1.39
Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet (1994) 1.38
Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry (1986) 1.37
Immunoglobulin-containing cells in multiple-sclerosis plaques. Lancet (1977) 1.33
Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res (1983) 1.29
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem (1983) 1.28
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry. Neuropathol Appl Neurobiol (1983) 1.24
Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain (2004) 1.23
The basis for behavioural disturbances in dementia. J Neurol Neurosurg Psychiatry (1996) 1.22
Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease. Lancet (1991) 1.21
Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. Dement Geriatr Cogn Disord (1998) 1.15
Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy. Clin Endocrinol (Oxf) (1987) 1.13
Asymmetry of pathology in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1987) 1.13
Immunocytochemical study of the cellular immune response in meningiomas. J Clin Pathol (1988) 1.13
The ACE gene and Alzheimer's disease susceptibility. J Med Genet (2000) 1.11
Experimental myositis in rats. I. Histological and creatine phosphokinase changes, and passive transfer to normal syngeneic rats. Clin Exp Immunol (1974) 1.10
Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol (1999) 1.09
Herpes simplex encephalitis. Immunohistological demonstration of spread of virus via olfactory pathways in mice. J Neurol Sci (1983) 1.08
Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case. J Neurol Neurosurg Psychiatry (1992) 1.08
Comparison of methods to identify microglial cells and macrophages in the human central nervous system. J Clin Pathol (1984) 1.07
Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol (1987) 1.07
The size and fiber composition of the anterior commissure with respect to gender and schizophrenia. Biol Psychiatry (1999) 1.06
Anomalous acetylcholinesterase in lumbar CSF in Alzheimer's disease. Lancet (1991) 1.06
Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol (2001) 1.05
Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK. J Neurol Neurosurg Psychiatry (2006) 1.05
Evidence for a role for apoptosis in central pontine myelinolysis. Acta Neuropathol (2002) 1.04
Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study. J Clin Pathol (1986) 1.04
Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement. Am J Med (1987) 1.04
Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. Dementia (1996) 1.03
Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol (1997) 1.02
The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol (1989) 1.02
Distribution of measles antigen and immunoglobulin-containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis. J Neurol Sci (1982) 1.01
The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience (1998) 1.01
Schizophrenia and temporal lobe asymmetry. A post-mortem stereological study of tissue volume. Br J Psychiatry (1999) 1.00
Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab (2000) 1.00
Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol (1999) 1.00
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med (1985) 1.00
Immunohistological study of granulovacuolar degeneration using monoclonal antibodies to neurofilaments. J Neurol Neurosurg Psychiatry (1985) 0.99
Viruses and Alzheimer's disease. J Neurol Neurosurg Psychiatry (1982) 0.99
Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci Lett (1999) 0.96
The cytoarchitecture of sulcal folding in Heschl's sulcus and the temporal cortex in the normal brain and schizophrenia: lamina thickness and cell density. Neurosci Lett (2004) 0.95
Evidence of axonal damage in human acute demyelinating diseases. J Neurol Sci (2004) 0.95
Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatry (1997) 0.95
A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophr Res (2003) 0.94
Neuronal cyclin expression in the hippocampus in temporal lobe epilepsy. Exp Neurol (1998) 0.94
Infection of murine striated muscle with Mycobacterium leprae: a study by light and electron microscopy. J Pathol (1972) 0.94
Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging (1998) 0.93
Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J Neurochem (1996) 0.93
Ultrastructural studies in human polymyositis. J Neurol Sci (1975) 0.93
Herpes simplex encephalitis: involvement of apolipoprotein E genotype. J Neurol Neurosurg Psychiatry (2001) 0.92
Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease. J Pathol (1996) 0.92
Role of matrix metalloproteinase 9 in pituitary tumor behavior. J Clin Endocrinol Metab (2000) 0.91
The hippocampus in schizophrenia: lateralized increase in neuronal density and altered cytoarchitectural asymmetry. Psychol Med (1997) 0.91
Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. J Endocrinol (2000) 0.90
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res (1987) 0.90
Comparison of pathological diagnostic criteria for Alzheimer disease. Alzheimer Dis Assoc Disord (1998) 0.90
Poliomyelitis: immunoglobulin-containing cells in the central nervous system in acute and convalescent phases of the human disease. Clin Exp Immunol (1980) 0.90
The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease. Neuroreport (2001) 0.88
Ubiquitinated inclusions in inclusion-body myositis patients are immunoreactive for cathepsin D but not beta-amyloid. Neurosci Lett (1995) 0.88
Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 1. Gliomas. J Neurol Sci (1991) 0.88